Source: SILVEC BIOLOGICS, INC. submitted to
USE OF NOVEL VECTOR TO DEFEAT FUNGAL PATHOGENS USING SIRNAS
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
ACTIVE
Funding Source
Reporting Frequency
Annual
Accession No.
1031059
Grant No.
2023-33610-40653
Cumulative Award Amt.
$650,000.00
Proposal No.
2023-03955
Multistate No.
(N/A)
Project Start Date
Sep 1, 2023
Project End Date
Aug 31, 2025
Grant Year
2023
Program Code
[8.2]- Plant Production and Protection-Biology
Project Director
Yang, S.
Recipient Organization
SILVEC BIOLOGICS, INC.
9600 GUDELSKY DR
ROCKVILLE,MD 208503467
Performing Department
(N/A)
Non Technical Summary
Plant fungal diseases present an ongoing and significant threat to global agriculture, causing approximately 10% of annual crop losses worldwide. These diseases not only result in substantial economic losses exceeding $200 billion annually but also raise concerns regarding the environmental and health impacts associated with fungicide use. Although resistant plant varieties and fungicides are commonly employed to protect crops against fungal diseases, they often prove insufficient in safeguarding vital tree, vine, and bush crops. The extensive use of fungicides is widespread, with a staggering 320,000 metric tons of fungicide active ingredients used globally in 2017 according to FAO statistics. For example, among the agricultural sectors facing formidable challenges, viticulture growers encounter significant difficulties combating devastating fungal diseases such as powdery mildew, grey mold, downy mildew, black rot, and anthracnose. The cultivated grapevine varieties belonging to Vitis vinifera, which comprise the majority of vineyards, lack genetic resistance and exhibit varying degrees of susceptibility to fungal infections. Consequently, extensive fungicide programs requiring multiple spray applications throughout the growing season are employed. In years conducive to epidemic development, an alarming amount of 19.5 kg/ha of active ingredients is annually applied to prevent fungal colonization. However, this reliance on repeated fungicide applications heightens the risk of developing fungicide resistance. Thus, there is an urgent economic imperative to seek new, effective, and environmentally sustainable control measures in trees and vines.Silvec is a pioneering company dedicated to developing innovative products that utilize RNA interference (RNAi) technology for controlling plant pathogens. Our groundbreaking approach centers around an internal delivery system employing a phloem-limited, independently mobile virus-like RNA (iRNA) vector. Dr. Anne Simon, a co-founder of Silvec and Chief Scientist, initially characterized this remarkable technology at the University of Maryland (UMd), where the invention originated. The iRNA vector is precisely engineered to incorporate an RNA segment that naturally converts into small interfering RNAs (siRNAs) within the plant. In an intriguing interplay between plants and pathogens, these small RNAs are taken up by fungi. Together with the protein complex RISC, they selectively bind to specific messenger RNAs (mRNAs) within the fungi, effectively silencing them and hindering the production of critical proteins. Silvec's research has yielded remarkable success, demonstrating a reduction in viral levels exceeding 3,000-fold by utilizing our engineered iRNA vector to inoculate plants against highly pathogenic viruses. As the exclusive licensee of UMd's iRNA vector technology, Silvec has primarily focused on combating the devastating bacterial disease Huanglongbing (HLB) in citrus trees. This disease has inflicted significant damage on citrus production in Florida and is rapidly spreading to other states. Our solution involves grafting infected plants with our iRNA vector, which carries inserted siRNA molecules and information for expressing anti-microbial peptides, effectively immunizing trees against harmful plant viral and bacterial pathogens.The SBIR funding enables Silvec to concurrently develop ongoing viral and bacterial products while expanding into fungal products. The ability to control gene expression and mitigate pathogen infections using RNA interference technology holds immense potential to revolutionize the agriculture industry, comparable to the impact of vaccines and antibiotics in human medicine. In phase I, we successfully demonstrated the potential of the CYVaV-siRNA platform to reduce the severity of gray mold disease in the model plant Nicotiana benthamiana. By targeting fungal genes susceptible to commercial fungicides, we achieved promising results. In phase II, our goal is to build upon the phase I findings and optimize the platform for full-scale commercial application in grapevines. Additionally, we aim to broaden the platform's scope to include other economically important fungal diseases such as powdery mildew. We will conduct assessments to evaluate the safety and environmental impact of the CYVaV vector, while larger-scale greenhouse trials will gauge the platform's effectiveness. Successful commercialization of the CYVaV-siRNA platform will provide grapevine growers and cultivators of trees, vines, and bushes with a secure, potent, and environmentally friendly solution for managing fungal diseases.Silvec is committed to advancing this technology and driving transformative change in the agricultural sector.By harnessing the unique capabilities of RNAi, Silvec is dedicated to making a transformative impact in the field of plant pathogen control, revolutionizing agriculture by providing effective solutions to a wide range of diseases affecting various crops and offering resilience and protection against harmful plant pathogens.
Animal Health Component
60%
Research Effort Categories
Basic
(N/A)
Applied
60%
Developmental
40%
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
21210991060100%
Goals / Objectives
The goal of SBIR phase II is to build upon the successful outcomes achieved in phase I and further develop a commercial process using Silvec's unique technology to effectively control pathogenic fungi, specifically targeting economically important trees and vines such as citrus and grapevines. The primary focus will be on addressing the causal agents of gray mold (Botrytis cinerea) and powdery mildew (Uncinula necator) and demonstrating the effectiveness of the technology in managing these fungal diseases.To achieve this goal, our research plan consists of four specific objectives, each designed to address critical aspects of the technology and its application:Objective 1: Design and optimize CYVaV-siRNA vectors with multiple antifungal RNAis for suppressing B. cinerea and U. necator in laboratory conditions. This objective involves designing and testing various siRNA constructs to identify the most effective ones for subsequent experiments. The optimization process will be carried out under controlled laboratory conditions.Objective 2: Generate mother plants that harbor CYVaV-siRNA vectors targeting B. cinerea and U. necator. This will be achieved by introducing CYVaV containing the optimized siRNA constructs identified in Objective 1 into target trees/vines using a suitable transformation method. The resulting plants will be evaluated for their efficacy in suppressing the target fungi.Objective 3: Evaluate the effectiveness of CYVaV vectors in suppressing B. cinerea and U. necator in trees/vines under greenhouse conditions. The efficacy of the vectors will be determined by measuring disease severity, yield, and quality. This objective aims to assess the performance of the technology in a controlled greenhouse environment, providing valuable insights into its potential commercial application.Objective 4: Assess potential off-target effects of RNAi and examine the environmental impact of the CYVaV platform on non-target organisms. This objective involves conducting experiments to evaluate the effects of the CYVaV-siRNA vectors on non-target organisms in plants. The results of these experiments will be crucial in validating the safety of the CYVaV-siRNA for use in commercial grape production and assessing any potential environmental impact.Upon achieving success, Silvec plans to collaborate with renowned budwood providers such as UC Davis's Foundation Plant Services (FPS), a major supplier of budwood scions to vineyards in the US, and growers like E&J Gallo, the world's largest wine producer (as expressed in their letter of support). The objective is to utilize the Silvec technology to vaccinate mother vines, ultimately aiming to develop a single iRNA vector containing stacked siRNAs capable of simultaneously targeting multiple fungi. This approach holds significant promise in extending the application of the technology to various plant species, effectively immunizing a wide range of plants against harmful fungi.Overall, the proposed research plan is expected to contribute to the development of a novel and effective approach to controlling plant fungal diseases. Successful achievement of these objectives will advance the technology's development towards commercialization and have a significant impact on commercial production.
Project Methods
To achieve the objectives of Phase II, our work plan combines laboratory experiments and greenhouse trials to optimize the CYVaV-siRNA platform, evaluate its efficacy in hosts, and assess its safety.The objectives and experiments are as follows:Objective 1: Design and optimize CYVaV-siRNA vectors to target multiple fungal pathogens. This objective involves 1) designing and optimizing interfering RNAs that target fungal essential genes identified in Phase Ias well as host Mlo and S genes; 2) validating RNAi fragments in vitro and CYVaV-siRNA vectors carrying them in detached hostleaves and in N. benthamiana to confirm antifungal activity. Our strategy involves selecting conserved regions (30-50 nucleotides) with predicted siRNA products in fungal Sdhc and Cyp51 genes, as well as host Mlo6, Mlo7, Dnd1, and Dmr6 genes. Combining these regions produces interfering RNAs (~97 nucleotides) compatible with Silvec's CYVaV-siRNA vector, following the methodology used in Phase I.To evaluate efficacy, we perform a two-step screening process: RNAs are synthesized in vitro and tested against multi-fungicide resistant B. cinerea using a MIC assay on a 96-well plate and B. cinerea growth inhibition isscreened against U. necator using detached leaves.Selected ~97-nt RNAi fragments with 90% inhibition at 5 ng/mL against B. cinerea are optimized into ~198-nt hairpin structures, following Silvec's unique hairpin design, and integrated into CYVaV-siRNA vectors. Vectors are delivered to detached leaves via agrobacterium infiltration. After air-drying, leaves are exposed to U. necator conidia. Disease severity is determined by quantifying powdery mildew coverage using Romero et al.'s (2003) method.To validate CYVaV vectors against B. cinerea and U. necator, vectors showing promising results in vitro (B. cinerea, MIC90 ≤ 5 ng/mL) and detached leaf assays (U. necator, ≥ 75% disease reduction) undergo further testing in N. benthamiana plants. Validation experiments follow the methods used in Phase I and the planned greenhouse trials for Objective 3.Objective 2: Generation of mother plants carrying CYVaV-siRNA vectors targeting multiple fungal pathogens. To achieve this, Silvec will focus on three tasks: 1) Generating stable grapevine mother plants containing the selected CYVaV-siRNA vectors using various transformation approaches; 2) Assessing the efficacy of grapevine mother plants against target fungal diseases; and 3) Scaling up mother plants carrying optimized CYVaV-siRNA vectors for greenhouse trials.For Task 1, Silvec will generate stable CYVaV-siRNA-infected mother plants using various methods. This includes agrobacterium-mediated vacuum infiltration by co-infiltrating the selected CYVaV vector with RNAi inserts along with the p14 gene into 6- to 8-week-old grapevineseedlings. Dodder bridged transmission will also be employed by transferring CYVaV1 from CYVaV1-infected N. benthamiana to mother plants using Cuscuta campestris dodder. PCR and Northern blotting will confirm and monitor the presence and stability of CYVaV-siRNA in host. Alternatively, the CYVaV-siRNA vector will be transgenically delivered into grapevines via agrobacterium and tissue culture. Task 2 involves assessing the efficacy of themother plants against targeted fungal diseases. Techniques like Stem-loop qPCR and Northern blotting will confirm the presence of siRNAs in the mother plants. The efficacy will be evaluated using a detached leaf assay method. For Task 3, Cuttings from positivemother plants will be grafted onto healthy plants. The presence of CYVaV-siRNA and interfering siRNAs will be monitored during the new flush period. The plantscarrying the CYVaV-siRNAs will be propagated and nurtured in the growth chamber and greenhouse at UMd.Objective 3: Greenhouse trials to evaluate the effectiveness of CYVaV-siRNA vectors in suppressing multi-fungal pathogens. Silvec proposes conducting scaled greenhouse trials to evaluate the efficacy of CYVaV-siRNA vectors in suppressing B. cinerea and U. necator in hosts. Additionally, the growth and health of grapevines carrying CYVaV-siRNA will be monitored during this phase, which is crucial for the commercialization of the antifungal product.Controlled disease evaluations will be carried out in an unsprayed shaded greenhouse. Disease evaluations will be conducted 2-4 weeks post-inoculation using a modified OIV-455 scale, as described by Pap et al. (2016). Similar procedures will be employed to evaluate gray mold disease in the grapevines carrying the selected CYVaV-siRNAs. Two milliliters of 50,000 conidia/ml in 0.1% (v/v) Tween solution of the botrytis spore inoculum generated from the multi-fungicide resistance strain used in phase I research will be applied to each plant using a Perval Sprayer unit. Disease severity will also be evaluated 2-4 weeks post-inoculation based on a scale of 0 to 4, as described by Rosero-Hernández et al. (2019).These growth and health evaluations will provide valuable data to assess the impact of the antifungal product on grapevine growth and development, which is crucial for successful commercialization. If CYVaV levels in grapevines do not reach sufficient levels to produce adequate siRNAs for fungal control, a second ulaRNA VIGS vector will be established. This ulaRNA, recently described in grapevines in Russia (February 2023), will have the hairpins mentioned earlier added to it, and experiments will be repeated following the same procedure as described for CYVaV.Objective 4: Assessment of potential off-target effects of RNAi and environmental impact of CYVaV platform on non-target organisms. To ensure compliance with safety regulations established by the EPA, we will conduct a series of experiments and analyses to evaluate potential off-target effects of the CYVaV-siRNA vectors on non-target organisms and the environment.Firstly, we will compare the genome-wide transcriptome profiles of healthy Chardonnay grapevines, grapevines harboring the wild-type CYVaV, and grapevines carrying selected CYVaV-siRNA vectors. This analysis aims to identify any potential off-target effects related to the siRNAs in grapevines. Approximately 100 mg of leaf tissue will be extracted from each grapevine type, and RNA will be extracted using a previously described method (Yang et al., 2017). RNA-Seq libraries will be constructed using the NEBNext Ultra RNA Library Prep Kit following the manufacturer's instructions (NEB), and sequencing will be performed using the Illumina HiSeq 2500 system. The resulting reads will be aligned to the Chardonnay grapevine reference sequence. Differential expressed genes will be identified using the DEGseq package, and non-target pathways will be analyzed using the EXPath Tool based on Gene Ontology and Kyoto Encyclopedia of Genes and Genomes databases.Secondly, we will conduct a metagenomic analysis to assess microbial biodiversity in grapevines carrying CYVaV with or without selected siRNAs. Grapevine leaf and root samples will be collected and processed as previously described. DNA extraction will be performed using a phenol-chloroform-based method, and a two-step PCR amplification will be carried out for the V5-V7 region of bacterial 16S rRNA, the fungal ITS1 region, and the oomycete ITS1 region of 18S rRNA. Blocking oligonucleotides, as described by Mayer et al. (2021), will be used to reduce plant DNA amplification. Purified PCR products will be pooled and sequenced on an Illumina MiSeq platform. The resulting sequences will be processed using the QIIME pipeline, and biodiversity analysis will be performed using the UPARSE pipeline and RDP classifier.Overall, these experiments will provide valuable data on the potential off-target effects of the CYVaV-siRNA vectors and their environmental impact on non-target organisms. The results will be crucial in determining the safety and regulatory compliance of the CYVaV platform.

Progress 09/01/23 to 08/31/24

Outputs
Target Audience: Nothing Reported Changes/Problems:The objective of this SBIR Phase II project is to expand on the successful outcomes of Phase I by advancing the development of a commercial process leveraging Silvec's innovative technology to effectively manage pathogenic fungi, with a particular focus on economically significant crops such as citrus and grapevines. Our research efforts have been primarily directed towards achieving the first two of four key objectives: 1) Design and optimize CYVaV-siRNA vectors incorporating multiple antifungal RNAi molecules to suppress B. cinerea and U. necator under controlled laboratory conditions and 2) Generate mother plants containing CYVaV-siRNA vectors that target B. cinerea and U. necator. As outlined in the preceding section, we have successfully designed and optimized CYVaV-siRNA vectors capable of inhibiting these fungal pathogens, including B. cinerea and the powdery mildew pathogen, in Nicotiana benthamiana. Moreover, we have successfully generated citrus plants infected with CYVaV-siRNA. However, subsequent investigations diverged from our preliminary observations--where CYVaV1 was detectable in systemic leaves six weeks post-infection in grapevines. We encountered difficulties in detecting CYVaV1 in systemic leaves after 24 weeks. Despite multiple independent attempts across various grape cultivars (Pinot Noir, Chardonnay, and Cabernet Franc), involving a total of 30 plants, we were unable to replicate the initial detection results. Comprehensive analyses, including RT-PCR and Northern blot assays, strongly indicate that CYVaV1 may not be suitable as a VIGS vector for grapevines. Consequently, we have initiated the investigation and development of alternative VIGS vectors tailored for grapevine applications. Actions taken to overcome this challenge: 1. Identification of Potential Grape VIGS Vectors: Through extensive literature review, four grape viruses causing asymptomatic infections have been identified as potential candidates for VIGS vector development: 1) Apple Latent Spherical Virus (ALSV), known as asymptomatic infections and effective RNAi activity in grapevines; 2) Grapevine Leaf Roll-associated Virus-2 SG isolate: known as asymptomatic infections and effective RNAi activity in grapevines; and 3) Umbra-like grape virus-4 (GULV-4): A newly identified virus from asymptomatic grapevines, related to Umbra viruses, showing promise as a VIGS vector. 2. Construction of Infectious Clones: We have successfully constructed full-length infectious clones for three viruses: ALSV (bipartite RNA genome ~4kb and ~7kb), GLRaV-2-SG (~16kb), and GULV-4 (~3.5kb). These constructs are currently being evaluated for infectivity in Nicotiana benthamiana and grapevines. What opportunities for training and professional development has the project provided? Nothing Reported How have the results been disseminated to communities of interest? Nothing Reported What do you plan to do during the next reporting period to accomplish the goals?Key Upcoming Activities Objective 2: Generate Mother Plants Harboring Relevant VIGS Vectors Targeting Botrytis cinerea and Uncinula necator a) Grapevine Mother Plant Generation: Develop grapevine mother plants infected with alternative VIGS vectors, such as ALSV, GLRaV2, and GLRaV7, incorporating Silvec's proprietary RNAi fragments targeting host genes (DMR6, DND1) and pathogen-critical genes (SDHC, CYP51). b) Determine Gene Silencing Efficiency: Assess the efficiency of target gene silencing in these mother plants. Objective 3: Evaluate the Effectiveness of VIGS Vectors in Suppressing Economically Important Fungal Pathogens in Trees/Vines Under Greenhouse Conditions a) Assess Vector Efficacy: Evaluate the performance of alternative VIGS vectors in grapevines and/or sweet orange by measuring disease severity, yield, and quality in the greenhouse at the University of Maryland. b) Monitor Plant Health: Track the growth and overall health of grapevines carrying CYVaV-siRNA constructs. Objective 4: Assess Potential Off-Target Effects of RNAi and Environmental Impact of Alternative VIGS Platforms on Non-Target Organisms a) Bioinformatic and Environmental Analysis: Conduct bioinformatic analyses to identify potential off-target effects of the VIGS vectors (ALSV, GLRaV2/7-siRNA in grapevines, or CTV in sweet orange) on non-target organisms, including soil microorganisms and beneficial insects, using appropriate assays. b) Analyze and Report Results: Analyze the results of all experiments and compile comprehensive reports.

Impacts
What was accomplished under these goals? The primary objective of the SBIR Phase II project is to advance and optimize a commercial process using Silvec's proprietary technology to effectively manage and control pathogenic fungi in economically significant trees and vines, particularly citrus and grapevines. This project specifically targets fungal pathogens like Botrytis cinerea (gray mold) and Erysiphe spp. (powdery mildew), which pose serious threats to these crops, causing substantial yield losses and diminishing produce quality.The two primary objectives for the first year are: (1) to design and optimize virus-induced gene silencing (VIGS) vectors, particularly CYVaV-based vectors, incorporating antifungal RNA interference (RNAi) sequences to suppress the genes responsible for susceptibility to gray mold and powdery mildew under controlled laboratory conditions; and (2) to generate mother plants that harbor these optimized vectors, targeting the pathogens in question. To achieve the first objective, extensive literature review identified 11 host susceptibility (S) genes as potential targets, including Downy Mildew Resistance 6 (DMR6), "Defense, No Death" (DND1 and DND2), Mildew Locus O 6 (MLO6), and others involved in fungal infection processes. Fungicide targets within the pathogens themselves, such as Succinate Dehydrogenase subunit C (SDHC) and Cytochrome P450 lanosterol 14α-demethylase (Cyp51/Erg11), were also considered. The project integrated 200 to 300 base pair (bp) regions of these target genes into tobacco rattle virus (TRV) VIGS vectors, which were then introduced into Nicotiana benthamiana plants to induce gene silencing. Gene silencing efficiency was quantified using quantitative reverse transcription PCR (qRT-PCR), revealing a 50-80% silencing efficiency for most target genes. Notably, silencing NbDMR6, NbMLO6, and NbDND1 significantly reduced powdery mildew severity by up to 95%. However, silencing NbDMR6 and NbMLO6 did not suppress Botrytis cinerea, whereas silencing NbEDR1 and NbDND1 effectively inhibited Botrytis growth, reducing disease severity by more than 80%. These findings highlight the complexity of plant-pathogen interactions and the need for targeting multiple genes to achieve broad-spectrum resistance. To optimize the silencing fragments for integration into Silvec's proprietary CYVaV1 vector, bioinformatics tools were used to predict optimal small interfering RNA (siRNA) regions within the NbDMR6, NbMLO6, and NbDND1 fragments. The 98-nucleotide (nt) regions with two potential siRNA sites were selected, optimized, and integrated into CYVaV1 VIGS vectors. These vectors were introduced into N. benthamiana plants, achieving up to 75% gene silencing. Disease evaluation indicated that the CYVaV1 VIGS vector containing the optimized NbDMR6 and NbMLO6 fragments could suppress powdery mildew by 40-50%. To achieve the second objective, efforts were made to generate mother plants for grapevine and citrus that harbor the optimized VIGS vectors targeting DMR6, MLO6, and DND1 genes. Initial attempts to introduce CYVaV1 vectors into grapevine were unsuccessful, likely due to the nonhost status of grapevines for the CYVaV virus or the plants' strong antiviral defenses. Despite multiple attempts, the novel vector could not be introduced into grapevines, underscoring the technical challenges of introducing foreign genetic material into nonhost species. In contrast, the project successfully obtained citrus mother trees infected with CYVaV1 carrying the DMR6 gene-silencing RNAi fragment. However, the gene silencing efficiency in citrus was lower than in N. benthamiana, suggesting the need for further optimization to enhance silencing efficiency in citrus. Factors such as differences in virus-host interactions or the stability of the VIGS vectors in citrus may have contributed to this lower efficiency. To overcome the challenges faced with grapevines and citrus, the project is adopting alternative VIGS vectors that have been successful in commercial plants. These vectors include citrus tristeza virus (CTV) for citrus and grapevine leafroll-associated viruses 2 and 7, as well as apple latent spherical virus (ALSV), which have been proven to infect grapevines. The team has successfully introduced CTV vectors targeting citrus DMR6 and DND1 genes into citrus plants. Additionally, efforts are underway to integrate optimized RNAi fragments into ALSV for gene silencing in grapevines. These alternative vectors offer a promising solution to the technical challenges encountered with CYVaV1 and may provide effective gene silencing in both citrus and grapevines. In summary, the SBIR Phase II project represents a significant advancement in developing biotechnological solutions for managing fungal diseases in high-value crops. The focus on designing and optimizing VIGS vectors, generating mother plants, and overcoming vector integration challenges is crucial for the commercial application of this technology. Silvec's approach has the potential to provide a sustainable and effective alternative to chemical fungicides, revolutionizing disease management practices in agriculture, enhancing crop productivity, reducing environmental impact, and improving economic outcomes for farmers and the agricultural industry.

Publications

  • Type: Journal Articles Status: Published Year Published: 2024 Citation: Ying X, Bera S, Liu J, Toscano-Morales R, Jang C, Yang S, et al. (2024) Umbravirus-like RNA viruses are capable of independent systemic plant infection in the absence of encoded movement proteins. PLoS Biol 22(4): e3002600. https://doi.org/10.1371/journal.pbio.3002600